Prevention and treatment, these three points are important

Source: Zhongyuan.com

Recently, the domestic epidemic has many points, a wide range, and frequency. In this context, how to effectively prevent new crown pneumonia is the issue that everyone cares about most. Since the epidemic of new coronary pneumonia, even the "three medicines and three parties" such as Qinghua have played a role.

The efficacy of basic research and application practice is reliable

The State Key Laboratory of Guangzhou Respiratory Diseases in the "Pharmaceutical Research" published by the mainstream journal of the international pharmacological community "Lianhua Qing Plague has antiviral and anti -inflammatory effects on the new coronary virus" found that Lianhua Qing Plague can significantly inhibit the new coronary virus in the flowers. Copy in cells, the expression of intracellular virus particles after the flowers were treated with flowers were significantly reduced.

The inflammatory storm is an excessive immune response caused by the body's stimulation of virus and bacteria. It has become an important node for new coronary pneumonia from mildness to severe and critical illness. Lianhua clearing plague can significantly inhibit the inflammatory factor TNF-A, IL-6, MCP-1 and IP-10 caused by the inflammatory factor caused by the new coronary virus infection cells. This study revealed the basis of the pharmacological role of the exact effect of Lianhua Qing Plague in the new crown pneumonia, and confirmed that the Lianhua Qingjuan expression was inhibited by inhibiting virus replication and inhibitory cell inflammation factor expression, thereby playing the role of anti -new coronary virus activity, as a company as a continuous The application of Huaqing Plague to treat new crown pneumonia provides an experimental basis.

The "Chinese Medicine Lianhua Qing Plague treatment of new type of coronary virus pneumonia forward, random, multi -center clinical research" jointly participated by more than 20 new coronary pneumonia collection hospitals in China. The results were published in the magazine " Botanical medicine. The results of the study show that the combined application of Lianhua Qingjuan Capsule is appreciated on the basis of conventional treatment. 14 days can significantly increase the improvement rate of clinical symptoms such as the fever, fatigue, and cough of the new crown pneumonia. Increase the clinical cure rate, shorten the time of nucleic acid to overcast, and have high safety.

Recently, the real world research papers "Lianhua Qing Plague Capsule Prevention of Coronary Virus Pneumonia" hosted by the Second Hospital of Hebei Medical University "was published by the international academic journal" Evidence -based Supplement and Alternative Medicine ". The effectiveness and safety of the dense contact of the new coronary pneumonia and the second -dense contact person. The application of the densely connected population can reduce the positive infection rate of new crown Luyanitis by 76%.

This time, the real world research conducted by the prevention of the new crown virus pneumonians in the prevention of the new crown virus pneumonia, and the subject who had a close contact with the infection with the new crown pneumonia was divided into the Lianhua Qing Plague intervention group (1101 cases) With the control group (875 cases), the Lianhua Qingjuan capsule (4 capsules, 3 times a day) or conventional medical observation for 14 days, the positive rate of nasopharynx wipe nucleic acid detection during medical isolation observation is used as the main evaluation indicator. Results proved that the positive rate of detection of the nucleic acid detection group of the Lianhua Qing Guan intervention group was significantly lower than that of the control group (0.27%vs.1.14%). safety.

"Chinese Medicine Lianhua Qing Plague Treatment of New Coronatte Pneumonic Polymoring, Random, Comparison, Multi -Center Clinical Research" shows that compared with the conventional treatment group in terms of reducing the proportion of rotation to %, Conventional treatment group 4.2%). This shows that the Lianhua Qingjuan capsule is used for the treatment of patients with new crown pneumonia, which can curb the deterioration of the disease of patients with new coronary pneumonia, showing a good trend in reducing the proportion of rotation, not only to improve clinical symptoms, but also improve the clinical ending.

Since the market entered the market in 2003, it has been recommended by more than 30 national level plans. From the influenza A influenza, type B, and bird flow, I feel new coronary virus pneumonia. In public health incidents, even Huaqing Plague has been recommended by the treatment plan, becoming a representative Chinese medicine for treating colds, anti -flu, and treating new crown pneumonia. It is aimed at fever, cough, phlegm sticky, sore throat, fatigue, muscle soreness and other syndrome. The mechanism of function is to use multiple targets to cooperate with anti -inflammatory, antiviral, cough and asthma. , Enhance the body's immune effect.

Therefore, in the context of the current domestic epidemic presentation, a wide range of points, wide, and frequent occurrences, prepare for the flowers of the flowers to clear the plague, which can make our work, study, and family rest assured.

- END -